Top Page
Alexium International Group
(Sydney:AJX)
Alexium International Group (AJX) vs. iShares MSCI Australia ETF (EWA)
Alexium International Group Business Overview & Revenue Model
Alexium International Group Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.55M | 3.92M | 5.89M | 7.19M | 8.14M | 7.29M |
| Gross Profit | 2.04M | 1.69M | 2.64M | 2.81M | 3.32M | 2.65M |
| EBITDA | -1.70M | -3.25M | -962.00K | -1.38M | -1.54M | 147.52K |
| Net Income | -2.14M | -3.93M | -2.76M | -2.95M | -3.36M | -1.45M |
Balance Sheet | ||||||
| Total Assets | 5.23M | 2.88M | 5.23M | 5.37M | 6.40M | 10.49M |
| Cash, Cash Equivalents and Short-Term Investments | 2.05M | 662.45K | 2.05M | 511.78K | 1.02M | 2.94M |
| Total Debt | 969.43K | 2.55M | 969.43K | 4.54M | 3.85M | 3.46M |
| Total Liabilities | 1.93M | 3.28M | 1.93M | 6.35M | 4.83M | 6.31M |
| Stockholders Equity | 3.30M | -402.08K | 3.30M | -980.26K | 1.57M | 4.18M |
Cash Flow | ||||||
| Free Cash Flow | -1.35M | -2.80M | -1.35M | -1.49M | -1.93M | -1.51M |
| Operating Cash Flow | -1.19M | -2.58M | -1.19M | -1.10M | -1.57M | -1.39M |
| Investing Cash Flow | -156.22K | -218.09K | -156.22K | -385.41K | -353.35K | -882.65K |
| Financing Cash Flow | 2.91M | 1.42M | 2.91M | 992.85K | 74.01K | 323.38K |
Alexium International Group Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
| ― | AU$42.67M | -5.52 | -67.76% | ― | 7.08% | 33.70% | |
| ― | AU$18.13M | -6.71 | -63.81% | ― | ― | 52.66% | |
| ― | AU$56.08M | -64.13 | -1.75% | ― | -5.37% | -140.00% | |
| ― | AU$93.46M | -4.43 | -22.28% | ― | 16.47% | 29.53% | |
| ― | €11.26M | -2.63 | -263.52% | ― | -32.85% | 28.30% | |
| ― | €38.01M | -4.07 | -869.14% | ― | 340.27% | 19.44% |
Alexium International Group Corporate Events
Alexium International Group Limited has announced the arrangements for its 2025 Annual General Meeting, inviting shareholders to participate in person or via a live stream. The meeting will be held on November 21, 2025, and shareholders are encouraged to submit proxy forms online by November 19, 2025. This meeting is a critical opportunity for stakeholders to engage with the company’s strategic direction and performance.
Alexium International Group Limited has announced an investor webinar scheduled for October 16, 2025, in Sydney and October 15, 2025, in Greer. The event will feature presentations from key company leaders, including the Interim Chair, CEO, and Vice President of Finance. This initiative aims to engage shareholders by allowing them to submit questions during the webinar, potentially enhancing transparency and communication with stakeholders.
Alexium International Group Limited has announced a change in the director’s interest, specifically concerning William Timothy Blackburn. The change involves the lapse of 22,843,648 Share Appreciation Rights, resulting in a decrease of securities held by the director. This adjustment reflects the company’s ongoing management of executive compensation and may influence shareholder perceptions regarding executive incentives and alignment with company performance.
Alexium International Group Limited announced the cessation of 32,476,019 share appreciation rights due to the expiry of options or other convertible securities without exercise or conversion as of September 23, 2025. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and market positioning.
Alexium International Group Limited has announced the postponement of its Investor Webinar originally scheduled for September 25-26, 2025. The webinar will now take place on October 15-16, 2025, and will provide a comprehensive update on the company’s business and new business opportunities that are in advanced stages of development. This postponement may impact stakeholders’ expectations and the company’s communication strategy.
Alexium International Group Limited announced a change in the director’s interest, with Paul Stenson acquiring 2,981,037 ordinary fully paid shares. These shares were issued in lieu of director remuneration for the first half of 2025, as approved by shareholders at the 2024 Annual General Meeting. This move reflects the company’s strategy to align management incentives with shareholder interests, potentially impacting its financial structure and stakeholder relations.
Alexium International Group Limited announced a change in the director’s interest, with T. Randall Lane acquiring 5,962,075 ordinary fully paid shares, increasing his total holdings to 7,899,743 shares. This acquisition was made in lieu of director remuneration for the first half of 2025, as approved by shareholders, indicating a strategic move to align the director’s interests with the company’s performance, potentially impacting stakeholder confidence and market perception positively.
Alexium International Group Limited announced a change in the director’s interest, with Simon Colinton Moore receiving shares in lieu of remuneration for the first half of 2025. This adjustment, approved by shareholders, reflects the company’s strategic approach to aligning director interests with company performance, potentially impacting stakeholder perceptions and reinforcing the company’s commitment to its financial strategies.
Alexium International Group Limited has issued 22,701,738 ordinary fully paid shares without disclosure under Part 6D.2 of the Corporations Act, as per a notice under section 708A(5) of the Act. The company confirms compliance with relevant provisions of the Corporations Act and states there is no ‘excluded information’ required to be disclosed. This move is authorized by the Board of Directors and reflects the company’s ongoing commitment to regulatory compliance and transparency.
Alexium International Group Limited announced the issuance of 22,701,738 ordinary shares as part of director remuneration, approved at the company’s Annual General Meeting in November 2024. This move is expected to impact the company’s financial structure and could influence its market positioning by aligning director interests with shareholder value.
Alexium International Group Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, highlighting its commitment to transparency and accountability. This disclosure is crucial for stakeholders as it confirms Alexium’s compliance with governance standards, potentially impacting investor confidence and the company’s market reputation.
Alexium International Group Limited has released its Appendix 4E and 2025 Annual Report, with plans for a FY2025 Results & FY2026 Trading Update webinar. This announcement highlights the company’s ongoing commitment to transparency and stakeholder engagement, potentially impacting its market positioning and stakeholder relations.
Alexium International Group faced a challenging FY25 with declining sales in its core mattress market, attributed to reduced product application amounts and prolonged sales cycles. Despite these financial setbacks, the company has successfully launched new products, creating significant opportunities with existing and new customers. While the US mattress market has seen a consistent decline post-pandemic, Alexium’s technological advancements position it for future growth, with a potential to quadruple its sales volume in FY26 once market conditions improve.